Inhaled Corticosteroids for Outpatients with Covid-19: A Meta-Analysis

  1. Todd C. Lee
  2. Émilie Bortolussi-Courval
  3. Sara Belga
  4. Nick Daneman
  5. Adrienne K. Chan
  6. Ryan Hanula
  7. Nicole Ezer
  8. Emily G. McDonald
1 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

The role of inhaled corticosteroids for outpatient COVID-19 is evolving. We meta-analyzed reported clinical trials and estimated probability of any effect and number needed to treat of 50 or 20 for symptom resolution by day 14 [100%, 99.8%, 93.1%] and hospitalization [89.3%, 72.9%, 26.7%] respectively.

Related articles

Related articles are currently not available for this article.